Patient Safety through Personalized Medicine and Innovation

Jacques Baer, DRA, Supply Chain and Market Access Solutions, Roche Pharmaceuticals (Israel) Ltd., Hod Hasharon, Israel (jacques.baer@roche.com)

This presentation will address the current R&D and innovation trends aiming to support improved diagnosis and treatment of cancer using new concepts such as Personalized Health Care, Real World Data, Meaningful Data at Scale and Patient Empowerment.  The goal of this presentation is to discuss the value of embedding safety and risk management throughout development activities while ensuring sustainable engagement of all stakeholders and achieving improved risk / benefit ratio for the patients.

---

Abstract Reference & Short Personal Biography of Presenting Author

Dr. Jacques Baer, Drug Regulatory Affairs Director at Roche Pharmaceuticals (Israel) Ltd. has over 25 years of experience in R&D, technology transfers, regulatory affairs, pharmaco-vigilance, quality assurance, market access and supply chain areas.  Jacques is a Pharm D and Pharmacologist by background (Louis Pasteur University, Strasbourg France), with international R&D and experience acquired at INSERM, Weizman Institute, pharmaceutical industry (Novartis, Teva, Roche).